MARKET

ZSAN

ZSAN

Zosano Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.070
-0.040
-3.60%
After Hours: 1.080 +0.01 +0.93% 19:58 04/13 EDT
OPEN
1.080
PREV CLOSE
1.110
HIGH
1.080
LOW
1.030
VOLUME
1.56M
TURNOVER
--
52 WEEK HIGH
3.060
52 WEEK LOW
0.3275
MARKET CAP
113.73M
P/E (TTM)
-1.8641
1D
5D
1M
3M
1Y
5Y
Cluster Headache Market Industry Analysis, Market Size, Trends, Share and Forecast 2027
Apr 12, 2021 (Market Insight Reports) -- The report on Cluster Headache provides the clients with an in-depth analysis of market share, market size, growth...
Market Insight Reports · 1d ago
Global Microneedle Drug Delivery Systems Market By Type, By Application, By Segmentation, By Region, and By Country
Apr 07, 2021 (Heraldkeepers) -- A microneedle device is made by arranging hundreds of microneedles in arrays on a tiny patch (the same as that of a normal...
Heraldkeepers · 6d ago
Top Penny Stocks Today To Add To Your April 2021 List
Penny Stocks · 04/06 18:21
Global Alternative Drug Delivery Systems Market Insights, Overview, Analysis and Forecast 2021
Apr 05, 2021 (Heraldkeepers) -- Global Alternative Drug Delivery Systems Market Overview:Global Alternative Drug Delivery Systems Market Report 2020 comes...
Heraldkeepers · 04/05 10:52
Global Needle-Free Drug Delivery Systems Market Outlook, Industry Analysis and Prospect 2018-2025
Apr 05, 2021 (Heraldkeepers) -- Needle free injection system provides solution of introducing several drugs into the host body without piercing the skin with...
Heraldkeepers · 04/05 08:45
Global Microneedle Transdermal Drug Delivery System Market 2020 Product Type, Applications, Market Share and Forecast by 2025
Mar 29, 2021 (CDN Newswire via Comtex) -- Global Microneedle Transdermal Drug Delivery System Market Growth 2020-2025 is extremely much required in some ways...
CDN Newswire · 03/29 17:14
Musculoskeletal Disorders Therapeutics Market Analysis 2021 Growth Opportunities, Trends, Segmentation and Outlook 2026, with Impact of COVID-19
Mar 24, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Musculoskeletal Disorders...
The Express Wire · 03/24 07:04
Migraine Drugs Market is Forecasted to grow at a rate of 3.37%, from USD 1851.23 Million in 2018 to USD 2375.62 Million in 2025 | Top Key Players- AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Alder Biopharmaceuticals Inc.
Mar 23, 2021 (Heraldkeepers) -- Migraine Drugs Market is valued around USD 1851.23 Million in 2018 and expected to reach USD 2375.62 Million by 2025 with the...
Heraldkeepers · 03/23 10:13
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ZSAN. Analyze the recent business situations of Zosano Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ZSAN stock price target is 2.167 with a high estimate of 2.500 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 48
Institutional Holdings: 11.46M
% Owned: 10.78%
Shares Outstanding: 106.29M
TypeInstitutionsShares
Increased
8
923.90K
New
6
366.52K
Decreased
8
1.74M
Sold Out
15
1.70M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.86%
Pharmaceuticals & Medical Research
+0.68%
Key Executives
Chairman/Director
John Walker
Chief Executive Officer/Director
Steven Lo
Chief Financial Officer
Christine Matthews
Senior Vice President
Dushyant Pathak
Vice President
Eric Scharin
Other
Thorsten von Stein
Director
Linda Grais
Director
Joseph Hagan
Independent Director
Steven Elms
Independent Director
Kenneth Greathouse
Independent Director
Kleanthis Xanthopoulos
No Data
  • All
  • Financials
  • Insiders
More
About ZSAN
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company. The Company is focused on providing systemic administration of therapeutics to patients using its Adhesive Dermally-Applied Microarray (ADAM) technology. ADAM is an intracutaneous delivery system designed to offer drug absorption into the bloodstream. ADAM consists of an array of drug-coated titanium microneedles mounted on an adhesive backing that is pressed on to the skin using a reusable handheld applicator. The Company’s Qtrypta (M207) is a formulation of zolmitriptan delivered utilizing its ADAM technology. Qtrypta (M207) is being investigated as a treatment to provide relief of migraine symptoms in the migraine cycle. The Company has developed its transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications.

Webull offers kinds of Zosano Pharma Corp stock information, including NASDAQ:ZSAN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZSAN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZSAN stock methods without spending real money on the virtual paper trading platform.